News & Insights

Showing 121–160 of 176

Embark-ing On the Public Markets

By Matthew Ocko

From Seed to IPO: Zymergen Brings Biofacturing Public

By Matthew Ocko, Zachary Bogue

Hermès + MycoWorks: A Match Made in Sustainable Luxury Heaven

By Dr. Kiersten Stead

Evolv Technology, the Leader in AI Touchless Security Screening, to Become Publicly Traded Company

Rocket Lab to Become Publicly Traded Commercial Orbital Launch Company

By Matthew Ocko, Dr. Chris Boshuizen

MindMed Acquires DCVC Company HealthMode

DCVC Announcements

2021 and Deep Tech: Reasons for Optimism

Introducing Capella Spotlight - Better Imaging for Better Insight

By Matthew Ocko, Dr. Chris Boshuizen

Deep Tech Innovations from the Ground Up

The Future of Repetitive, Physically Demanding and Dangerous Work: DCVC Co-leads Investment in Agility Robotics

By Matthew Ocko

Using Biology-as-a-Platform to Move from Treatment to Cure

By Zachary Bogue

Life sciences and Deep Tech: The next set of solutions to the next set of problems

By Dr. Kiersten Stead, Dr. John Hamer, Matthew Ocko, Zachary Bogue

DCVC Leads Series B Financing in Caption Health

An Update on How Deep Tech is Arming the Fight Against COVID-19

By Matthew Ocko, Zachary Bogue

Alpha Marketing: Be Like Mike

Investing in Proprio: New Needs Need New Techniques

Pivot Bio Raises $100m Series C: Bringing Microbes to Millions...of Acres

By Matthew Ocko

Atoms, After Bits

DCVC Announcements

Highlights from the DCVC Team

Powering a Comprehensive Response to the COVID-19 Crisis Through Deep Tech

By Matthew Ocko, Zachary Bogue

DCVC Announcements

Former Command Senior Enlisted Leader of USSOCOM Patrick McCauley Joins DCVC as Operating Partner

Solving the world’s hardest problems with Deep Tech: Request for Startups

By Ali Tamaseb, Matthew Ocko

Caption Health Secures FDA Authorization for First-in-Class AI-Guided Medical Ultrasound

Powering the Next Battery Revolution, Advano Decloaks From Stealth With $18.5m Series A

By James Hardiman

DCVC Announcements

DCVC x Women in Robotics Event

DCVC Announcements

DCVC V

Element AI raises $151M Series B to enable artificial intelligence at the heart of every company

By Matthew Ocko, Zachary Bogue

From endpoint to infrastructure, SentinelOne advances autonomous, AI-driven cybersecurity with $120M Series D

By Matthew Ocko, Zachary Bogue

Medical Informatics: Bringing deep compute and empathy to the ICU

Reimagining biologics: AbCellera and Novartis partner to find new disease treatments

By Dr. John Hamer

DCVC Announcements

Joining DCVC

Computationally-bred microbe fertilizer for corn decreases pollution, saves farmers money and time, and increases crop yields 4.4%+ in world of <1% recent yield gains

By Matthew Ocko, Zachary Bogue

AbCellera Raises $10M Series A: Deep Search for the Immune System

By Matthew Ocko, Zachary Bogue

DCVC Bio leads GenEdit’s $8.5 Million Seed Round: Safe, efficient CRISPR and gene therapy delivery platform proven across multiple diseases and cell types

By Matthew Ocko, Zachary Bogue

Rocket Lab raises $140M Series E, demonstrates back-to-back smallsat launches for revenue

By Matthew Ocko, Zachary Bogue

Primer AI, Series A led by DCVC, raises $40M+ Series B to scale commercialization of AI that reads and writes like a human

By Matthew Ocko, Zachary Bogue

Zymergen, Series Seed and Series A led by DCVC, Raises $400M+ Series C: Revolutionizing global industry through molecular manufacturing

By Matthew Ocko, Zachary Bogue

DCVC leads Reach Labs' $9M Series A to make scalable, far-field wireless power a reality

By Matthew Ocko, Zachary Bogue

StarkWare Raises $30M Series A to Build Post-Quantum Secure Blockchain

By Matthew Ocko

More Productive Farmers, a Cleaner World, $212 Billion a Year of Revenue on the Table

By Matthew Ocko, Zachary Bogue